Cargando…

Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies

BACKGROUND: Non-invasive prenatal testing (NIPT) has been widely used to detect common fetal chromosome aneuploidies, such as trisomy 13, 18, and 21 (T13, T18, and T21), and has expanded to sex chromosome aneuploidies (SCAs) during recent years, but few studies have reported NIPT detection of rare f...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Ying, Zhao, Guodong, Li, Hong, Zhang, Qin, Lu, Jiafeng, Yu, Bin, Wang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584990/
https://www.ncbi.nlm.nih.gov/pubmed/31249627
http://dx.doi.org/10.1186/s13039-019-0441-5
_version_ 1783428614537084928
author Xue, Ying
Zhao, Guodong
Li, Hong
Zhang, Qin
Lu, Jiafeng
Yu, Bin
Wang, Ting
author_facet Xue, Ying
Zhao, Guodong
Li, Hong
Zhang, Qin
Lu, Jiafeng
Yu, Bin
Wang, Ting
author_sort Xue, Ying
collection PubMed
description BACKGROUND: Non-invasive prenatal testing (NIPT) has been widely used to detect common fetal chromosome aneuploidies, such as trisomy 13, 18, and 21 (T13, T18, and T21), and has expanded to sex chromosome aneuploidies (SCAs) during recent years, but few studies have reported NIPT detection of rare fetal chromosome aneuploidies (RCAs). In this study, we evaluated the clinical practical performance of NIPT to analyze all 24 chromosome aneuploidies among 57,204 pregnancies in the Suzhou area of China. METHODS: This was a retrospective analysis of prospectively collected NIPT data from two next-generation sequencing (NGS) platforms (Illumina and Proton) obtained from The Affiliated Suzhou Hospital of Nanjing Medical University. NIPT results were validated by karyotyping or clinical follow-up. RESULTS: NIPT using the Illumina platform identified 586 positive cases; fetal karyotyping and follow-up results validated 178 T21 cases, 49 T18 cases, 4 T13 cases, and 52 SCAs. On the Proton platform, 270 cases were positive during NIPT. Follow-up confirmed 85 T21 cases, 17 T18 cases, 4 T13 cases, 28 SCAs, and 1 fetal chromosome 22 aneuploidy case as true positives. There were 5 false-negative results, including 4 T21 and 1 T18 cases. The NGS platforms showed similar sensitivities and positive predictive values (PPVs) in detecting T21, T18, T13 and SCAs (p > 0.01). However, the Proton platform showed better specificity in detecting 45, X and the Illumina platform had better specificity in detecting T13 (p < 0.01). The major factor contributing to NIPT false-positives on the Illumina platform was false SCAs cases (65.11%). Maternal chromosome aneuploidies, maternal cancers, and confined placental mosaicism caused discordant results between fetal karyotyping and NIPT. CONCLUSION: NIPT with NGS showed good performance for detecting T13, T18, and T21. The Proton platform had better performance for detecting SCAs, but the NIPT accuracy rate for detecting RCAs was insufficient.
format Online
Article
Text
id pubmed-6584990
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65849902019-06-27 Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies Xue, Ying Zhao, Guodong Li, Hong Zhang, Qin Lu, Jiafeng Yu, Bin Wang, Ting Mol Cytogenet Research BACKGROUND: Non-invasive prenatal testing (NIPT) has been widely used to detect common fetal chromosome aneuploidies, such as trisomy 13, 18, and 21 (T13, T18, and T21), and has expanded to sex chromosome aneuploidies (SCAs) during recent years, but few studies have reported NIPT detection of rare fetal chromosome aneuploidies (RCAs). In this study, we evaluated the clinical practical performance of NIPT to analyze all 24 chromosome aneuploidies among 57,204 pregnancies in the Suzhou area of China. METHODS: This was a retrospective analysis of prospectively collected NIPT data from two next-generation sequencing (NGS) platforms (Illumina and Proton) obtained from The Affiliated Suzhou Hospital of Nanjing Medical University. NIPT results were validated by karyotyping or clinical follow-up. RESULTS: NIPT using the Illumina platform identified 586 positive cases; fetal karyotyping and follow-up results validated 178 T21 cases, 49 T18 cases, 4 T13 cases, and 52 SCAs. On the Proton platform, 270 cases were positive during NIPT. Follow-up confirmed 85 T21 cases, 17 T18 cases, 4 T13 cases, 28 SCAs, and 1 fetal chromosome 22 aneuploidy case as true positives. There were 5 false-negative results, including 4 T21 and 1 T18 cases. The NGS platforms showed similar sensitivities and positive predictive values (PPVs) in detecting T21, T18, T13 and SCAs (p > 0.01). However, the Proton platform showed better specificity in detecting 45, X and the Illumina platform had better specificity in detecting T13 (p < 0.01). The major factor contributing to NIPT false-positives on the Illumina platform was false SCAs cases (65.11%). Maternal chromosome aneuploidies, maternal cancers, and confined placental mosaicism caused discordant results between fetal karyotyping and NIPT. CONCLUSION: NIPT with NGS showed good performance for detecting T13, T18, and T21. The Proton platform had better performance for detecting SCAs, but the NIPT accuracy rate for detecting RCAs was insufficient. BioMed Central 2019-06-20 /pmc/articles/PMC6584990/ /pubmed/31249627 http://dx.doi.org/10.1186/s13039-019-0441-5 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Xue, Ying
Zhao, Guodong
Li, Hong
Zhang, Qin
Lu, Jiafeng
Yu, Bin
Wang, Ting
Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies
title Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies
title_full Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies
title_fullStr Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies
title_full_unstemmed Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies
title_short Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies
title_sort non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584990/
https://www.ncbi.nlm.nih.gov/pubmed/31249627
http://dx.doi.org/10.1186/s13039-019-0441-5
work_keys_str_mv AT xueying noninvasiveprenataltestingtodetectchromosomeaneuploidiesin57204pregnancies
AT zhaoguodong noninvasiveprenataltestingtodetectchromosomeaneuploidiesin57204pregnancies
AT lihong noninvasiveprenataltestingtodetectchromosomeaneuploidiesin57204pregnancies
AT zhangqin noninvasiveprenataltestingtodetectchromosomeaneuploidiesin57204pregnancies
AT lujiafeng noninvasiveprenataltestingtodetectchromosomeaneuploidiesin57204pregnancies
AT yubin noninvasiveprenataltestingtodetectchromosomeaneuploidiesin57204pregnancies
AT wangting noninvasiveprenataltestingtodetectchromosomeaneuploidiesin57204pregnancies